Changzhou Qianhong Biopharma Co Ltd (002550) — Free Cash Flow Generation Index
Changzhou Qianhong Biopharma Co Ltd (002550) has a Free Cash Flow Generation Index of 0.90x as of September 2025. Free cash flow of CN¥140.76 Million represents 1% of operating cash flow (CN¥156.34 Million). Explore 002550 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Changzhou Qianhong Biopharma Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Changzhou Qianhong Biopharma Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Changzhou Qianhong Biopharma Co Ltd (002550) cash flow conversion.
Annual Free Cash Flow Generation for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Changzhou Qianhong Biopharma Co Ltd. Check how aggressively does Changzhou Qianhong Biopharma Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | CN¥219.76 Million | CN¥361.36 Million | CN¥141.60 Million | ▼ -26.2% |
| 2024 | 0.82x | CN¥424.07 Million | CN¥514.71 Million | CN¥90.64 Million | ▲ +1.5% |
| 2023 | 0.81x | CN¥433.00 Million | CN¥533.33 Million | CN¥100.33 Million | ▲ +537.6% |
| 2021 | 0.13x | CN¥13.19 Million | CN¥103.56 Million | CN¥90.37 Million | ▼ -84.1% |
| 2020 | 0.80x | CN¥254.74 Million | CN¥317.28 Million | CN¥62.53 Million | ▲ +113.1% |
| 2019 | 0.38x | CN¥60.87 Million | CN¥161.55 Million | CN¥100.68 Million | ▲ +112.3% |
| 2018 | -3.07x | CN¥-78.08 Million | CN¥25.45 Million | CN¥103.53 Million | ▼ -30538.8% |
| 2017 | 0.01x | CN¥892.39K | CN¥88.52 Million | CN¥87.63 Million | ▼ -97.3% |
| 2016 | 0.37x | CN¥82.08 Million | CN¥221.01 Million | CN¥138.94 Million | ▲ +50.4% |
| 2015 | 0.25x | CN¥70.73 Million | CN¥286.50 Million | CN¥215.78 Million | ▼ -61.5% |
| 2014 | 0.64x | CN¥161.49 Million | CN¥252.01 Million | CN¥90.53 Million | ▲ +212.7% |
| 2013 | 0.20x | CN¥32.88 Million | CN¥160.47 Million | CN¥127.59 Million | ▼ -69.8% |
| 2012 | 0.68x | CN¥135.62 Million | CN¥199.82 Million | CN¥64.20 Million | ▼ -17.3% |
| 2011 | 0.82x | CN¥120.51 Million | CN¥146.82 Million | CN¥26.31 Million | ▼ -12.5% |
| 2010 | 0.94x | CN¥160.88 Million | CN¥171.51 Million | CN¥10.64 Million | ▲ +256.1% |
| 2009 | -0.60x | CN¥-5.02 Million | CN¥8.35 Million | CN¥13.37 Million | ▼ -169.6% |
| 2008 | 0.86x | CN¥46.95 Million | CN¥54.36 Million | CN¥7.41 Million | ▲ +7.1% |
| 2007 | 0.81x | CN¥29.02 Million | CN¥35.99 Million | CN¥6.97 Million | — |